Cargando…
Impact of Genetics on Neoadjuvant Therapy with Complete Pathological Response in Metastatic Colorectal Cancer: Case Report and Review of the Literature
Treatment of colorectal metastatic cancer is still challenging, despite recent improvements in chemotherapy. A genetic cancer profile, such as the KRAS (Kirsten rat sarcoma) gene status, plays a key role in individualized tailored therapy. Molecular targeted therapy added to neo-adjuvant chemotherap...
Autores principales: | Bulajic, P, Bidzic, N, Djordjevic, V, Ceranic, Μ, Βasaric, D, Pesic, V, Djordjevic-Pesic, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714337/ https://www.ncbi.nlm.nih.gov/pubmed/31523624 http://dx.doi.org/10.2478/bjmg-2019-0004 |
Ejemplares similares
-
Subclinical hypothyroidism: association with cardiovascular risk factors and components of metabolic syndrome
por: Pesic, Milica M., et al.
Publicado: (2015) -
Liver resection versus transarterial chemoembolization for huge hepatocellular carcinoma: a propensity score matched analysis
por: Bogdanovic, A., et al.
Publicado: (2021) -
Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy
por: Baron, Paul, et al.
Publicado: (2015) -
Beyond Geometry: Classic Papers from Riemann to Einstein
por: Pesic, Peter
Publicado: (2007) -
Pathologic Complete Response to Neoadjuvant Nivolumab/Ipilimumab in a Patient with Metastatic Renal Cell Carcinoma
por: Peak, Taylor C., et al.
Publicado: (2020)